| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |